IP Library Patent Application 14405320
Patent Application
App. No. 14/405,320

HIGH-CONCENTRATION STEM CELL PRODUCTION METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/405,320
Abstract

The present invention relates to a method for preparing stem cells in high concentration. The present invention makes it possible to grow stem cells in an amount sufficient to be clinically usable in a short time, and makes it possible to relatively efficiently enhance the ability of administered stem cells to efficaciously reach target tissue and exhibit an action in a stable fashion and can therefore dramatically increase the efficacy of cell therapy using stem cells.

Claims (6)

1 . A method for preparing stem cells at a high concentration of 1×10 7 ˜5×10 8 cells/ml, the method comprising culturing stem cells in a medium containing a basal medium; and at least two components selected from the group consisting of N-acetyl-L-cysteine (NAC), ascorbic acid, insulin or insulin-like factor, hydrocortisone, dexamethasone, bFGF (basic fibroblast growth factor), heparan sulfate, 2-mercaptoethanol, EGF (epidermal growth factor), and antioxidant.

2 . The method of claim 1 , wherein the basal medium is selected from the group consisting of M199/F12 (mixture) (GIBCO), MEM-alpha medium (GIBCO), low-concentration glucose-containing DMEM medium (Welgene), MCDB 131 medium (Welgene), IMEM medium (GIBCO), K-SFM, DMEM/F12 medium, PCM medium, and MSC expansion medium (Chemicon).

3 . The method of claim 1 , wherein the antioxidant is selected from the group consisting of selenium, ascorbic acid, vitamin E, catechin, lycopene, β-carotene, coenzyme Q-10, EPA (eicosapentaenoic acid), and DHA (docosahexanoic acid).

4 . The method of claim 3 , wherein the antioxidant is selenium.

5 . The method of claim 1 , wherein the medium additionally contains a component selected from the group consisting of FBS (fetal bovine serum), calcium, and EGF.

6 . The method of claim 1 , wherein the stem cells are adipose tissue-derived mesenchymal stem cells.

Assignments (2)
CHANGE OF NAME Recorded Apr 1, 2016
From: K-STEMCELL CO., LTD.
To: R BIO CO., LTD
Reel/Frame 038581/0456 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2014
From: RA, JEONG CHAN; KANG, SUNG KEUN; JO, JUNG YOUN
To: K-STEMCELL CO., LTD.; RA, JEONG CHAN
Reel/Frame 034362/0140 →